Enterprise Value
518.7M
Cash
238.2M
Avg Qtr Burn
-37.45M
Short % of Float
11.88%
Insider Ownership
1.67%
Institutional Own.
97.51%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
DYNE-251 Details Duchenne muscular dystrophy | Phase 1/2 Data readout | |
DYNE-101 Details Myotonic Dystrophy Type 1 | Phase 1/2 Data readout |